[1]
“Atopic dermatitis: severity and control assessment during the COVID-19 pandemic, and determination of cardiovascular risk in adults”., Rev Alerg Mex, vol. 69, no. 2, pp. 72–77, Feb. 2023, doi: 10.29262/ram.v69i2.1067.